Spring 2024: VireXbuster was awarded for its innovative and effective disease control technology by GHP
Frankfurt, Oct. 13th 2021: Fraunhofer Institut has tested VireXbuster is effective against Coronavirus (99.9%)
 
Frankfurt, 18. Nov. 2021: DaXem ist nun offizieller Lieferant der UNO
Frankfurt, Nov. 5th 2021: Daxem is now member of AMICI

News Dashboard

VireXbuster Spray

The COVID-19 pandemic has changed everyone’s life. Despite masks, social distancing, and vaccinations, which are all important measures, the virus continues to mutate and circulate. According to the makers of VireXbuster Spray, individuals can potentially touch 5 infected surfaces in an hour. And results of a study have confirmed that individuals touch their face up to an average of 20-plus times per hour, thus potentially exposing themselves to the SARS-CoV-2 virus.1 Using the VireXbuster spray can interrupt this infection transmission channel by keeping frequently touched surfaces continuously disinfected with a permanent and affordable antiviral and antimicrobial coating.
Enrico Brega, chief operations officer for DaXem GmBh, which invented and manufactures VireXbuster Spray, said to ICT®. “Our ultimate goal is to provide our customers with coating solutions that improve their quality of life so that they can live in a safer and more hygienic environment. Furthermore, the underlying technology of our products is a patented hybrid coating composition that has 2 important characteristics, namely excellent biocidal properties toward a broader spectrum of biocide activity combined with high compatibility with most substrates.”
According to DaXem GmBh, a single application of VireXbuster Spray coating will keep surfaces hygienically clean for up to 12 months; in addition, VireXbuster Spray deactivates SARS-CoV-2 by 99.9% and kills bacteria such as Escherichia coli and Staphylococcus aureus by 99.99%. VireXbuster Spray helps repair scratched surfaces, filling the thin grooves where viruses and bacteria can settle.

Discover how VireXbuster can revolutionize dental practices by providing effective antimicrobial protection.

The Importance of Infection Control in Dentistry

Infection control is a crucial aspect of dental practices. With the constant exposure to various bacteria, viruses, and other pathogens, dentists and their staff must prioritize the prevention of infections in their clinics. Patients rely on dental professionals to maintain a safe and hygienic environment during their visits, and infection control plays a vital role in achieving this.
By implementing strict infection control protocols, dental practices can minimize the risk of cross-contamination and ensure the safety of both patients and staff. This includes proper sterilization of instruments, regular disinfection of surfaces, and the use of reliable antimicrobial solutions.
VireXbuster offers an innovative solution to enhance infection control in dentistry. Its antimicrobial coating provides a protective barrier against a wide range of microorganisms, including bacteria, fungi, and viruses. With VireXbuster, dental practices can significantly reduce the risk of infections and create a safer environment for everyone.

Introducing VireXbuster: The 99,99% effective Antimicrobial Solution

VireXbuster is a cutting-edge antimicrobial coating designed specifically for hospitals and dental practices. It is formulated with advanced technology that effectively eliminates microorganisms on various surfaces, providing long-lasting protection against harmful pathogens.
This revolutionary solution is easy to apply and dries quickly, leaving behind an invisible protective layer. VireXbuster’s antimicrobial properties continue to work even after multiple cleanings, ensuring continuous protection against bacteria, viruses, and fungi.
The unique formulation of VireXbuster makes it suitable for a wide range of surfaces commonly found in dental clinics, including countertops, dental chairs, and equipment. Its versatility and effectiveness make it an essential tool in the fight against infections in dental practices.

Benefits of Using VireXbuster in Dental Practices

Using VireXbuster in dental practices offers numerous benefits for both patients and dental professionals. One of the key advantages is the enhanced infection control it provides. By applying VireXbuster to surfaces, dental clinics create a protective barrier that prevents the growth and spread of harmful microorganisms.
In addition to its antimicrobial properties, VireXbuster also helps in maintaining a clean and hygienic environment. Its easy application and quick drying time make it a convenient solution for busy dental practices. Regular use of VireXbuster can significantly reduce the time and effort required for thorough disinfection and cleaning.
Furthermore, VireXbuster contributes to the overall safety and well-being of dental staff and patients. By minimizing the risk of infections, it ensures a healthier environment for everyone involved in the dental care process.
Overall, the benefits of using VireXbuster in dental practices are numerous, ranging from improved infection control to increased efficiency in maintaining cleanliness and hygiene.

Case Studies: Successful Implementation of VireXbuster in Dental Clinics

Several dental clinics have already implemented VireXbuster into their infection control protocols with remarkable success. These case studies demonstrate the positive impact of VireXbuster on the overall safety and hygiene of dental practices.
In one case study, a dental clinic observed a significant reduction in the occurrence of infections among both patients and staff after incorporating VireXbuster into their daily cleaning routine. The antimicrobial coating provided an added layer of protection, which resulted in improved patient satisfaction and increased confidence in the clinic’s infection control measures.
Another case study highlighted the cost-effectiveness of using VireXbuster. By reducing the risk of infections, the clinic experienced a decrease in the number of cancelled appointments and the need for additional treatments to address complications arising from infections.
These case studies serve as evidence of the effectiveness of VireXbuster in dental clinics and further support its value in enhancing infection control practices.

Future of Dental Care: How VireXbuster is Shaping the Industry

As the dental industry continues to evolve, the importance of infection control becomes increasingly prominent. Dental practices are constantly seeking innovative solutions to ensure the safety of their patients and staff, and VireXbuster is at the forefront of this revolution.
VireXbuster’s advanced antimicrobial technology is paving the way for a new standard in infection control. Its ability to provide long-lasting protection against a wide range of pathogens sets it apart from traditional cleaning and disinfection methods.
With the increasing awareness of the importance of infection control, dental practices are expected to embrace solutions like VireXbuster to enhance their protocols and safeguard the well-being of their patients. The future of dental care is being shaped by advancements in infection control, and VireXbuster is leading the way.

Combating COVID-19 with VireXbuster: A Novel Disinfectant Spray for Hospital Surfaces

As healthcare facilities continue to navigate the challenges of the COVID-19 pandemic, the need for effective disinfection solutions has never been greater. Hospitals, clinics, and other medical environments require robust sanitization protocols to protect patients, staff, and visitors from the spread of the SARS-CoV-2 virus. One innovative product helping hospitals rise to this challenge is VireXbuster Spray.
VireXbuster Spray is a cutting-edge long-lasting disinfectant formulated to quickly and thoroughly eliminate a broad spectrum of pathogens, including the COVID-19 virus. Developed by a team of leading virologists and chemists, this non-toxic, solvent-based solution has been rigorously tested and proven effective against even the toughest viruses and bacteria.
“VireXbuster has been a game-changer in our efforts to keep our hospital safe and sanitized during the pandemic,” said Dr. Emily Ramirez. “Its ability to kill COVID-19 on contact, while also being gentle on surfaces and hospital equipment, makes it an invaluable tool in our infection control arsenal.”
Unlike many traditional disinfectants, VireXbuster Spray is free of nano-materials and copper, making it safe for use around patients and staff. Its up to 12 months long lasting formula ensures environmental sustainability without compromising efficacy. The spray can be easily applied to a wide range of high-touch surfaces, including doorknobs, countertops, medical devices, and more, providing comprehensive protection against viral transmission.
“Maintaining a clean, disinfected environment is crucial for infection prevention in healthcare settings,” explained Dr. Ramirez. “VireXbuster Spray allows us to do that quickly, efficiently, and with the peace of mind that we are using a product that is both effective against virus, bacteria and fungi, and safe for our patients and staff.”
As hospitals continue to navigate the evolving challenges of the COVID-19 pandemic, innovative disinfection solutions like VireXbuster Spray will play a vital role in keeping medical facilities safe and operational. By combining proven efficacy, user-friendly application, and eco-friendly ingredients, VireXbuster is poised to become a standard in hospital infection control.

Frankfurt, 28. Jan. 2022:

VireXbuster® Spray has today been certified by dermatest GmbH – a German-based Dermatology laboratory. The result has been tested as „excellent“.

VireXbuster Spray is from now dermatologically tested.

The United States is currently reassessing its pandemic response and updating infection control strategies. Experts believe that another pandemic is highly likely to occur in the next few decades, whether it is caused by a lab-leaked virus or arises naturally. Some COVID-19 experts estimate a 20% chance of experiencing an outbreak similar to the Omicron variant within the next two years.

 

Despite this potential future threat, the ongoing COVID-19 pandemic is not yet under control. Recent news of a significant COVID-19 surge in Okinawa, Japan, with cases 25 times higher than baseline and more severe than previous waves, raises concerns about what the United States may face in the coming months.

 

SARS-CoV-2, the virus causing COVID-19, is transitioning into an endemic phase in the United States, with a seroprevalence of over 96%. This does not mean the virus is eradicated through herd immunity, but rather that a more constant level of infections may persist. Long COVID continues to take a toll on society, with insufficient support for affected patients. A significant number of Americans have left the workforce due to long COVID, leading to substantial economic losses.

 

Given these circumstances, it is crucial to mitigate the spread of diseases and reduce the number of infections. Long COVID, for instance, only develops if one becomes infected with SARS-CoV-2.

 

Moreover, besides SARS-CoV-2, other diseases like methicillin-resistant Staphylococcus aureus (MRSA), and other antibiotic-resistant infections are on the rise. Screening plays a pivotal role in controlling these illnesses. Studies have shown the effectiveness of MRSA screening before surgery and hospital admission in preventing infections. The United Kingdom’s National Health Service (NHS) routinely performs hospital admission screening.

 

Data from the United States Veterans Health Administration (VHA) demonstrates that MRSA screening can significantly reduce hospital-onset infections in acute care settings. However, publicly available data regarding MRSA, COVID-19, and other pathogens in the United States are lacking. Making this data readily accessible to the public would promote awareness of current risks and help address the issue of multi-drug resistant organisms.

 

Unfortunately, current infectious disease policies seem to be lacking in addressing these problems and, in some cases, are retreating. Draft CDC Healthcare Infection Control Practices Advisory Committee (HICPAC) recommendations need to adequately address screening. Some proposed policies, such as Enhanced Barrier Precautions (EBP), have raised concerns, as they may not provide sufficient protection against transmission.

 

In summary, a proactive and data-driven approach to infection control, including comprehensive screening, is crucial to mitigate the impact of current and potential future pandemics and the rise of antibiotic-resistant infections.

 

In addition to the measures mentioned earlier, another effective tool in combating the transmission of viruses, bacteria, and fungi is VireXbuster Spray. VireXbuster Spray is an antimicrobial coating spray specially designed to create a protective barrier on surfaces. This innovative spray has demonstrated effectiveness against various pathogens, including viruses, bacteria, and fungi, making it a versatile solution for infection control.

 

Once applied, VireXbuster Spray forms a long-lasting protective shield on surfaces, capable of lasting for months. This durable coating actively combats the survival and spread of harmful microorganisms, providing an added layer of defense against infection.

 

With VireXbuster Spray, the risk of transmission through touch on infected surfaces can be significantly reduced. By inhibiting the survival and growth of pathogens on treated surfaces, the spray helps create a cleaner and safer environment, especially in high-traffic areas and shared spaces.

 

Including VireXbuster Spray in infection control strategies can complement other preventive measures, such as regular handwashing, proper hygiene practices, and social distancing. Together, these measures form a comprehensive approach to minimize the spread of infectious diseases, both in the current COVID-19 pandemic and potential future outbreaks.

 

By incorporating VireXbuster Spray into public spaces, workplaces, healthcare facilities, and homes, we can take proactive steps to protect ourselves and others from infections, providing greater peace of mind and contributing to the overall well-being of our communities.

DaXem now approved UN supplier

Frankfurt, 18. Nov. 2021: DaXem GmbH, the producer of VireXbuster® Spray has been approved by the UN organization as supplier for antimicrobial and biocidal surface coatings.

 

 

DaXem now official member of AMiCI

Frankfurt, 5. November 2021: DaXem GmbH is now an official and accredited member of AMICI, the European Consortium active in the realm of development and promotion of new anti-microbial coatings. AMiCI stands for Anti-Microbial Coating Innovations, and has set out to prevent the spread of infectious diseases.

VireXbuster® is tested by the Fraunhofer Institute

Frankfurt, 13. Oktober  2021: VireXbuster® Spray, DaXem’s antimicrobial product, has been tested by the Fraunhofer Institute in Leipzig for the product’s efficacy against the Coronavirus, by 99,99 %.

VireXbuster® is tested by the QualityLab in Nuremberg

Frankfurt, 12. Sept. 2021: QualityLabs in Nuermberg has certified that VireXbuster® is particularly effective with regards to protecting our environment against bacteria. The certified efficacy is at 99.9%.